A variant associated with nicotine dependence, lung cancer and peripheral arterial disease
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Smoking is a leading cause of preventable death, causing about 5 million premature deaths worldwide each year. Evidence for genetic influence on smoking behaviour and nicotine dependence (ND) has prompted a search for susceptibility genes. Furthermore, assessing the impact of sequence variants on smoking-related diseases is important to public health. Smoking is the major risk factor for lung cancer (LC) and is one of the main risk factors for peripheral arterial disease (PAD). Here we identify a common variant in the nicotinic acetylcholine receptor gene cluster on chromosome 15q24 with an effect on smoking quantity, ND and the risk of two smoking-related diseases in populations of European descent. The variant has an effect on the number of cigarettes smoked per day in our sample of smokers. The same variant was associated with ND in a previous genome-wide association study that used low-quantity smokers as controls, and with a similar approach we observe a highly significant association with ND. A comparison of cases of LC and PAD with population controls each showed that the variant confers risk of LC and PAD. The findings provide a case study of a gene-environment interaction, highlighting the role of nicotine addiction in the pathology of other serious diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These biobank efforts, pioneered in studies such as the Framingham Cohort70 and the efforts of DeCODE in Iceland71,72, now encompass a growing inventory of national cohorts in North America, Europe, Asia and beyond73–76.”
From A brief history of human disease genetics (2020) · cites this paper as [72]
In the citing paper
“This association has been replicated either directly or using highly correlated SNPs by several groups (92–97).”
From Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery (2009) · cites this paper as [96]
In the citing paper
“The replicated nicotine dependence loci tagged by rs16969968 (96,100–102) and rs578776 (101,103) have also been reported to influence lung cancer risk in several genome-wide association studies.”
From Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery (2009) · cites this paper as [96]
In the citing paper
“This second association with nicotine dependence has been replicated in additional studies using the same SNP or a highly correlated SNP (92,95,96,98).”
From Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery (2009) · cites this paper as [96]
In the citing paper
“some indicate that the association could be explained through an indirect effect on risk for smoking (96)”
From Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery (2009) · cites this paper as [96]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Global Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,196
The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire
HEATHERTON, T. F., KOZLOWSKI, L. T., FRECKER, R. C., & FAGERSTROM, K. (1991) · British Journal of Addiction · doi:10.1111/j.1360-0443.1991.tb01879.x · Cited by 10,738
Hirsch, A. T., Haskal, Z. J., Hertzer, N. R., Bakal, C. W., Creager, M. A., Halperin, J. L., Hiratzka, L. F., Murphy, W. R. C., Olin, J. W., Puschett, J. B., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.174526 · Cited by 3,708
Recommended standards for reports dealing with lower extremity ischemia: Revised version
Rutherford, R. B., Baker, J. D., Ernst, C., Johnston, K. W., Porter, J. M., Ahn, S., & Jones, D. N. (1997) · Journal of Vascular Surgery · doi:10.1016/s0741-5214(97)70045-4 · Cited by 3,562
Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
Grant, S. F. A., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Manolescu, A., Sainz, J., Helgason, A., Stefansson, H., Emilsson, V., Helgadottir, A., et al. (2006) · Nature Genetics · doi:10.1038/ng1732 · Cited by 2,287
Self-citationGenotype-environment interaction and correlation in the analysis of human behavior.
Plomin, R., DeFries, J. C., & Loehlin, J. C. (1977) · Psychological Bulletin · doi:10.1037/0033-2909.84.2.309 · Cited by 1,685
Dormandy, J., & Rutherford, R. B. (2000) · PubMed · Cited by 1,635
Tanoue, L. T. (2007) · Yearbook of Medicine · doi:10.1016/s0084-3873(08)70176-7 · Cited by 1,413
Peto, R. (2000) · BMJ · doi:10.1136/bmj.321.7257.323 · Cited by 1,409
Cited by
Items 201–300 of 1,002
Lawlor, D. A., Richmond, R., Warrington, N., McMahon, G., Smith, G. D., Bowden, J., & Evans, D. M. (2017) · Wellcome Open Research · doi:10.12688/wellcomeopenres.10567.1 · Cited by 129
Bierut, L. J. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.10.004 · Cited by 120
Baker, T. B., Weiss, R. B., Bolt, D., von Niederhausern, A., Fiore, M. C., Dunn, D. M., Piper, M. E., Matsunami, N., Smith, S. S., Coon, H., et al. (2009) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntp064 · Cited by 120
“Three new genome-wide association studies provide strong evidence for an association between CHRNA5-A3-B4 variants and lung cancer, but they differ on whether the connection is direct or mediated by smoking behavior ( Amos et al., 2008 ; Hung et al., 2008 ; Thorgeirsson et al., 2008 ).”
BackgroundInfluentialAssociation of the CHRNA5-A3-B4 Gene Cluster With Heaviness of Smoking: A Meta-Analysis
Ware, J. J., van den Bree, M. B. M., & Munafò, M. R. (2011) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntr118 · Cited by 118
“…et al., 2008), smoking quantity (Amos et al., 2008; Berrettini et al., 2008; Keskitalo et al., 2009; Lips et al., 2009; Stevens et al., 2008; Thorgeirsson et al., 2008), and smoking cessation (Freathy et al., 2009) as well as smoking-related diseases, such as lung cancer (Amos et al., 2008;…”
BackgroundMethodResultInfluentialGenetics of alcohol dependence
Gelernter, J., & Kranzler, H. R. (2009) · Human Genetics · doi:10.1007/s00439-009-0701-2 · Cited by 119
King, D. P., Paciga, S., Pickering, E., Benowitz, N. L., Bierut, L. J., Conti, D. V., Kaprio, J., Lerman, C., & Park, P. W. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.232 · Cited by 120
“Figure 2 shows the time to relapse associated with the two most predictive SNPs, rs11606194 and rs3758987.”
BackgroundMethodResultInfluentialGenome-wide association study of smoking behaviours in patients with COPD
Siedliński, M., Cho, M. H., Bakke, P. S., Gulsvik, A., Lomas, D. A., Anderson, W. J., Kong, X., Rennard, S. I., Beaty, T. H., Hokanson, J. E., et al. (2011) · Thorax · doi:10.1136/thoraxjnl-2011-200154 · Cited by 123
Görlich, A., Antolin-Fontes, B., Ables, J. L., Frahm, S., Ślimak, M. A., Dougherty, J. D., & Ibañez-Tallon, I. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1313103110 · Cited by 108
“Converging evidence from genome-wide association studies and animal models has strongly implicated the nicotinic receptor subunits α3, α5, and β4 with heavy tobacco use and decreased success in smoking-cessation therapy in humans (7, 8), and with nicotine aversion and withdrawal in laboratory animals (6, 9, 10).”
BackgroundGenome‐wide association scans for secondary traits using case‐control samples
Monsees, G. M., Tamimi, R. M., & Kraft, P. (2009) · Genetic Epidemiology · doi:10.1002/gepi.20424 · Cited by 117
Variation at theTERTlocus and predisposition for cancer
Baird, D. M. (2010) · Expert Reviews in Molecular Medicine · doi:10.1017/s146239941000147x · Cited by 131
Lissowska, J., Foretová, L., Dabek, J., Zaridze, D. G., Szeszenia‐Dąbrowska, N., Rudnai, P., Fabiánová, E., Cassidy, A., Mateș, D., Bencko, V., et al. (2010) · Cancer Causes & Control · doi:10.1007/s10552-010-9537-2 · Cited by 143
“38), did not provide consistent findings as to the impact of the variants on the propensity to smoke versus a direct carcinogenic effect [9-12].”
BackgroundResultWang, Y., Broderick, P., Matakidou, A., Eisen, T., & Houlston, R. S. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp287 · Cited by 112
The translational challenges of precision oncology
Pich, O., Bailey, C., Watkins, T. B. K., Zaccaria, S., Jamal‐Hanjani, M., & Swanton, C. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.04.002 · Cited by 124
The “Iron”-y of Iron Overload and Iron Deficiency in Chronic Obstructive Pulmonary Disease
Cloonan, S. M., Mumby, S., Adcock, I. M., Choi, A. M. K., Chung, K. F., & Quinlan, G. J. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201702-0311pp · Cited by 106
Quach, B. C., Bray, M. J., Gaddis, N. C., Liu, M., Palviainen, T., Minica, C. C., Zellers, S., Sherva, R., Aliev, F., Nothnagel, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19265-z · Cited by 118
Polygenic risk scores for schizophrenia and bipolar disorder associate with addiction
Reginsson, G. W., Ingason, A., Euesden, J., Bjornsdottir, G., Olafsson, S., Sigurdsson, E., Oskarsson, H., Tyrfingsson, T., Runarsdottir, V., Hansdottir, I., et al. (2018) · Addiction Biology · doi:10.1111/adb.12496 · Cited by 112
“FTND data were obtained from questionnaires answered by participants in deCODE’s study of nicotine dependence (ND) (2004–2014)(Thorgeirsson et al. 2008).”
MethodSelf-citationLevey, D. F., Galimberti, M., Deak, J. D., Wendt, F. R., Bhattacharya, A., Koller, D., Harrington, K. M., Quaden, R. M., Johnson, E. C., Gupta, P., et al. (2023) · Nature Genetics · doi:10.1038/s41588-023-01563-z · Cited by 131
“While nicotinic receptors are also associated with tobacco smoking-related traits 24 , the relative pattern of association for those traits is different from the observations for CanUD—for many smoking-related traits, a chromosome 15 nicotinic receptor cluster is associated with orders of magnitude…”
ResultChromosome 4q31 locus in COPD is also associated with lung cancer
Young, R. P., Whittington, C. F., Hopkins, R. J., Hay, B. A., Epton, M., Black, P., & Gamble, G. D. (2010) · European Respiratory Journal · doi:10.1183/09031936.00033310 · Cited by 116
A Risk Model for Lung Cancer Incidence
Hoggart, C. J., Brennan, P., Tjønneland, A. M., Vogel, U. B., Overvad, K., Østergaard, J. N., Kaaks, R., Canzian, F., Boeing, H., Steffen, A., et al. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0237 · Cited by 120
“We also investigated the effects of 2 single-nucleotide polymorphisms (SNP) at loci which showed significant association with lung cancer incidence in genome-wide association studies (GWAS); these were rs8034191 on chromosome 15q25 (10, 24, 25) and rs402710 at 5p15 (26, 27).”
BackgroundGenome‐wide association studies for discovery of genes involved in asthma
Akhabir, L., & Sandford, A. J. (2011) · Respirology · doi:10.1111/j.1440-1843.2011.01939.x · Cited by 122
Lambrechts, D., Buysschaert, I., Zanen, P., Coolen, J., Lays, N., Cuppens, H., Groen, H. J. M., Dewever, W., van Klaveren, R. J., Verschakelen, J., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200909-1364oc · Cited by 113
“If genetic variability in nAChR only determines nicotine intake and smoking addiction, the rs1051730 variant may independently increase susceptibility of all smoking-related diseases, including emphysema and COPD (2).”
BackgroundNew mechanisms and perspectives in nicotine withdrawal
Jackson, K. J., Muldoon, P. P., De Biasi, M., & Damaj, M. I. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.11.009 · Cited by 104
“, 2009) and smoking related disease (Thorgeirsson et al., 2008; Amos et al., 2008; Hung et al., 2008; Wang et al., 2009; Falvella et al., 2009), fewer studies have examined the influence of this gene cluster in smoking cessation, with contradictory findings.”
InfluentialLind, P. A., Macgregor, S., Vink, J. M., Pergadia, M. L., Hansell, N. K., de Moor, M. H. M., Smit, A. B., Hottenga, J.-J., Richter, M. M., Heath, A. C., et al. (2010) · Twin Research and Human Genetics · doi:10.1375/twin.13.1.10 · Cited by 107
A decade in psychiatric GWAS research
Horwitz, T., Lam, K., Chen, Y., Xia, Y., & Liu, C. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0055-z · Cited by 105
“rs1051730 was linked to smoking behavior [15–17] and nicotine dependence [14] (combined into “nicotine-related phenotypes”), post bronchodilator FEV1, post bronchodilator FEV1/FVC ratio, pre bronchodilator FEV1, pre bronchodilator FEV1/FVC”
BackgroundImprogo, M. R. D., Scofield, M. D., Tapper, A. R., & Gardner, P. D. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.05.003 · Cited by 104
“…et al., 2009; Greenbaum and Lerer, 2009; Grucza et al., 2008; Le Marchand et al., 2008; Saccone et al., 2007, 2009a,b; Schlaepfer et al., 2008; Schwartz et al., 2009; Spitz et al., 2008; Stevens et al., 2008; Thorgeirsson et al., 2008; Vink et al., 2009; Wang et al., 2009a; Weiss et al., 2008).”
BackgroundInfluentialStriatal α5 Nicotinic Receptor Subunit Regulates Dopamine Transmission in Dorsal Striatum
Exley, R., McIntosh, J. M., Marks, M. J., Maskos, U., & Cragg, S. J. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.4985-11.2012 · Cited by 104
“Striatal 5 Nicotinic Receptor Subunit Regulates Dopamine”
BackgroundYuan, J., Gao, Y.-T., Murphy, S. E., Carmella, S. G., Wang, R., Zhong, Y., Moy, K. A., Davis, A. B., Li, T., Chen, M., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0209 · Cited by 115
Saccone, N. L., Schwantes‐An, T. ‐., Wang, J. C., Grucza, R. A., Breslau, N., Hatsukami, D., Johnson, E. O., Rice, J. P., Goate, A. M., & Bierut, L. J. (2010) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2010.00608.x · Cited by 103
“…et al. 2009; Grucza et al. 2008; Hung et al. 2008; Le Marchand et al. 2008; Lips et al. 2009; Liu et al. 2008; Pillai et al. 2009; Saccone et al. 2007; Sherva et al. 2008; Spitz et al. 2008; Stevens et al. 2008; Thorgeirsson et al. 2008; Wang et al. 2009; Weiss et al. 2008; Young et al. 2008).”
Pulmonary preneoplasia – sequential molecular carcinogenetic events
Lantuéjoul, S., Salameire, D., Salon, C., & Brambilla, E. M. (2009) · Histopathology · doi:10.1111/j.1365-2559.2008.03182.x · Cited by 119
“Very recently, a nicotinic acetylcholine receptor gene variant (acethyl choline receptors 3 and 5) at 15q24 has been identified and is suspected of being responsible for a higher risk of lung cancer and ⁄ or for nicotine addiction.(8,9) According to the 2004 World Health Organization (WHO) histological classification,…”
BackgroundVariants in nicotinic acetylcholine receptors α5 and α3 increase risks to nicotine dependence
Chen, X., Chen, J., Williamson, V. S., An, S., Hettema, J. M., Aggen, S. H., Neale, M. C., & Kendler, K. S. (2009) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30919 · Cited by 104
“During preparation of this article, two other reports of association between variants at the CHRNA5, CHRNA3, and CHRNB4 loci at 15q25 and heavy smoking/nicotine dependence were published [Bierut et al., 2008; Thorgeirsson et al., 2008].”
InfluentialGenome-wide association studies in common cancers—what have we learnt?
Varghese, J. S., & Easton, D. F. (2010) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.03.012 · Cited by 120
Lung cancer gene associated with COPD: triple whammy or possible confounding effect?
Young, R. P., Hopkins, R. J., Hay, B. A., Epton, M., Black, P., & Gamble, G. D. (2008) · European Respiratory Journal · doi:10.1183/09031936.00093908 · Cited by 111
Hardin, M., Zielinski, J., Wan, E. S., Hersh, C. P., Castaldi, P. J., Schwinder, E., Hawrylkiewicz, I., Sliwinski, P., Cho, M. H., & Silverman, E. K. (2012) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2012-0011oc · Cited by 104
“In the first GWAS of COPD, the CHRNA3/5 SNP rs8034191 was associated with an increased risk for COPD (8).”
BackgroundInfluentialYang, T., Guo, X., Wang, H., Fu, S., Wen, Y., & Yang, H. (2015) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2015.01.021 · Cited by 104
“This alkaloid is easily absorbed in humans, leading to a variety of negative physiological effects including cancer, pulmonary and cardiovascular disease (Thorgeirsson et al., 2008; Haley et al., 1985).”
BackgroundGenome-wide meta-analyses of smoking behaviors in African Americans
David, S. P., Hamidovic, A., Chen, G. K., Bergen, A. W., Wessel, J., Kasberger, J., Brown, W. M., Petruzella, S., Thacker, E. L., Kim, Y., et al. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.41 · Cited by 113
“1.(3) Genome-wide meta-analyses in three large consortia (n1⁄4 74 053, 31 226 and 41 150) of smoking behaviors confirmed the finding at 15q25.”
ResultNicotine dependence and genetic variation in the nicotinic receptors
Bierut, L. J. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.06.003 · Cited by 100
“…15 and tagged by rs16969968, the variant that results in an amino acid change, is now recognized as one of the strongest genetic determinants of lung cancer risk in several high-profile lung cancer genome wide association studies (Amos et al., 2008; Hung et al., 2008; Thorgeirsson et al., 2008).”
Zienolddiny, S., Skaug, V., Landvik, N. E., Ryberg, D., Phillips, D. H., Houlston, R. S., & Haugen, A. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp131 · Cited by 107
Hung, R. J., Christiani, D. C., Risch, A., Popanda, O., Haugen, A., Zienolddiny, S., Benhamou, S., Bouchardy, C., Lan, Q., Spitz, M. R., et al. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0411 · Cited by 109
“Future prospects of ILCCO include multistage validation and fine mapping for possible causative genetic regions identified from ongoing genome-wide association studies (26-28).”
BackgroundAutoimmunity in chronic obstructive pulmonary disease: clinical and experimental evidence
Kheradmand, F., Shan, M., Xu, C., & Corry, D. B. (2012) · Expert Review of Clinical Immunology · doi:10.1586/eci.12.7 · Cited by 107
Mechanisms involved in lung cancer development in COPD
Caramori, G., Casolari, P., Cavallesco, N. G., Giuffré, S., Adcock, I. M., & Papi, A. A. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.08.022 · Cited by 105
Boscarino, J., Erlich, Hoffman, & Zhang (2012) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s29508 · Cited by 97
“The CHRNA5 gene has been associated with smoking and nicotine dependence.(21,22) PTSD is known to be associated with cigarette smoking.”
Epigenetic signatures of starting and stopping smoking
McCartney, D. L., Stevenson, A. J., Hillary, R. F., Walker, R. M., Bermingham, M. L., Morris, S. W., Clarke, T., Campbell, A., Murray, A. D., Whalley, H. C., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.10.051 · Cited by 108
“Therewas no association betweenmisclassification of current smokers to the never smoker–enriched cluster and sex, alcohol consumption, batch, or genotype at the well–established nicotine addiction genetic variant rs1051730, (P ≥ 0·103; Supplementary Table 4) [20].”
BackgroundMethodThe CHRNA5–A3–B4 gene cluster in nicotine addiction
Berrettini, W. H., & Doyle, G. A. R. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.122 · Cited by 102
Withdrawal: Expanding a Key Addiction Construct
Piper, M. E. (2015) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntv048 · Cited by 93
The Impact of Divergence Time on the Nature of Population Structure: An Example from Iceland
Price, A. L., Helgason, A., Palsson, S., Stefansson, H., St. Clair, D., Andreassen, O. A., Reich, D., Kong, A., & Stefansson, K. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000505 · Cited by 103
“The Icelandic population has been sampled in many disease association studies [1–8].”
MethodSelf-citationCommon pathogenic mechanisms and pathways in the development of COPD and lung cancer
Yang, I. A., Relan, V., Wright, C. M., Davidson, M. R., Sriram, K. B., Francis, S. M. S., Clarke, B. E., Duhig, E., Bowman, R., & Fong, K. M. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.555400 · Cited by 106
“Spinola 2007 [116] 335 smokers 338 smokers Affymetrix (116,204) 10p KLF6 Amos 2008 [117] 1154 smokers 1137 smokers Illumina (317,498) 15q CHRNA3 Hung 2008 [118] 1989 smokers 2625 smokers Illumina (317,139) 15q CHRNA3, CHRNA5 Thorgeirsson 2008 [119] 1024 smokers 32,244 controls Illumina (306,207) 15q CHRNA3 McKay 2008…”
Assessing the utility of intermediate phenotypes for genetic mapping of psychiatric disease
Flint, J., Timpson, N., & Munafò, M. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2014.08.007 · Cited by 92
Genetic Advances in Chronic Obstructive Pulmonary Disease. Insights from COPDGene
Ragland, M. F., Benway, C. J., Lutz, S. M., Bowler, R. P., Hecker, J., Hokanson, J. E., Crapo, J. D., Castaldi, P. J., DeMeo, D. L., Hersh, C. P., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201808-1455so · Cited by 116
Young, R. P., Hopkins, R. J., Whittington, C. F., Hay, B. A., Epton, M., & Gamble, G. D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016476 · Cited by 101
“The authors suggest that some important associations may be either missed [18,19] or miss-assigned [17–19] in studies where the COPD status of smoking controls is unknown, especially using hospital based controls where the prevalence of COPD has been found to be as high as 30% [33].”
BackgroundAssociation study of 182 candidate genes in anorexia nervosa
Pinheiro, A. P., Bulik, C. M., Thornton, L. M., Sullivan, P. F., Root, T. L., Bloss, C. S., Berrettini, W. H., Schork, N. J., Kaye, W. H., Bergen, A. W., et al. (2010) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31082 · Cited by 92
“…for T1DM, T2DM, Crohn’s disease, cardiovascular disease, prostate cancer, breast cancer, body mass index, nicotine addiction, and height [Bierut et al., 2007; Consortium, 2007; Frayling et al., 2007; Saxena et al., 2007; Scott et al., 2007; Berrettini et al., 2008; Thorgeirsson et al., 2008].”
Backgroundand the COPDGene and ECLIPSE Investigators, Siedliński, M., Tingley, D. H., Lipman, P. J., Cho, M. H., Litonjua, A. A., Sparrow, D., Bakke, P. S., Gulsvik, A., Lomas, D. A., et al. (2013) · Human Genetics · doi:10.1007/s00439-012-1262-3 · Cited by 102
Shiraishi, K., Kohno, T., Kunitoh, H., WATANABE, S.-I. J., Goto, K., Nishiwaki, Y., Shimada, Y., Hirose, H., Saito, I., Kuchiba, A., et al. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn257 · Cited by 99
The Impact of Genetic Research on our Understanding of Normal Cognitive Ageing: 1995 to 2009
Payton, A. (2009) · Neuropsychology Review · doi:10.1007/s11065-009-9116-z · Cited by 95
“Reports of interactions are now increasing exponentially for a wide variety of diseases and traits including cancer (Thorgeirsson et al. 2008), asthma (Kim et al. 2009) and obesity (Qi and Cho 2008).”
BackgroundApplying Tobacco Carcinogen and Toxicant Biomarkers in Product Regulation and Cancer Prevention
Hecht, S. S., Yuan, J., & Hatsukami, D. K. (2010) · Chemical Research in Toxicology · doi:10.1021/tx100056m · Cited by 107
Temperament and brain networks of attention
Posner, M. I., & Rothbart, M. K. (2018) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2017.0254 · Cited by 101
Acetylcholine receptors: Key players in cancer development
Chen, J., Cheuk, I., Shin, V. Y., & Kwong, A. (2019) · Surgical Oncology · doi:10.1016/j.suronc.2019.09.003 · Cited by 101
Chen, H.-Y., Yu, S.-L., Ho, B.-C., Su, K.-Y., Hsu, Y.-C., Chang, C.-S., Li, Y.-C., Yang, S.-Y., Hsu, P.-Y., Ho, H., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.3590 · Cited by 94
Zhong, H., & Prentice, R. L. (2010) · Genetic Epidemiology · doi:10.1002/gepi.20437 · Cited by 94
Wu, X., Ye, Y., Rosell, R., Amos, C. I., Stewart, D. J., Hildebrandt, M. A. T., Roth, J. A., Minna, J. D., Gu, J. H., Lin, J. M., et al. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr075 · Cited by 101
Girard, N., Lou, E., Azzoli, C. G., Reddy, R., Robson, M., Harlan, M., Orlow, I., Yatabe, Y., Nafa, K., Ladanyi, M., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2437 · Cited by 94
Does nicotine replacement therapy cause cancer? Evidence from the Lung Health Study
Murray, R. P., Connett, J. E., & Zapawa, L. M. (2009) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntp104 · Cited by 93
Sarginson, J. E., Killen, J. D., Lazzeroni, L. C., Fortmann, S. P., Ryan, H. S., Schatzberg, A. F., & Murphy, G. M. (2011) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31155 · Cited by 92
“…diseases, including lung cancers andperipheral vascular disease [Amos et al., 2008;Hung et al., 2008; LeMarchand et al., 2008; Spitz et al., 2008; Thorgeirsson et al., 2008; Falvella et al., 2009; Wang et al., 2009a], and a number of other forms of addiction [Grucza et al., 2008; Chen et al.,…”
BackgroundInfluentialNicotinic acetylcholine receptor variation and response to smoking cessation therapies
Bergen, A. W., Javitz, H. S., Krasnow, R., Nishita, D., Michel, M., Conti, D. V., Liu, J., Lee, W., Edlund, C. K., Hall, S., et al. (2013) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32835cdabd · Cited by 90
The habenula in psychiatric disorders: More than three decades of translational investigation
Fakhoury, M. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.02.010 · Cited by 98
DNA repair phenotype and cancer susceptibility—A mini review
Li, C., Wang, L., & Wei, Q. (2008) · International Journal of Cancer · doi:10.1002/ijc.24126 · Cited by 96
Gene-Environment Dependence Creates Spurious Gene-Environment Interaction
Dudbridge, F., & Fletcher, O. (2014) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2014.07.014 · Cited by 93
Brand, J. S., Gaillard, R., West, J., McEachan, R. R. C., Wright, J., Voerman, E., Felix, J. F., Tilling, K., & Lawlor, D. A. (2019) · PLOS Medicine · doi:10.1371/journal.pmed.1002972 · Cited by 90
“Instrument selection and genotyping for MR We selected the rs1051730 single nuclear polymorphism (SNP) in the α-nicotinic acetylcholine receptor (CHRNA3/5) gene cluster as an instrumental variable for our MR analysis because this variant has been shown to robustly (in genome-wide discovery and replication studies [17,…”
BackgroundMethodEgleton, R. D., Brown, K. C., & Dasgupta, P. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.10.007 · Cited by 96
Kullo, I. J., & Leeper, N. J. (2015) · Circulation Research · doi:10.1161/circresaha.116.303518 · Cited by 88
Variants near CHRNA3/5 and APOE have age- and sex-related effects on human lifespan
Joshi, P. K., Fischer, K., Schraut, K. E., Campbell, H., Esko, T., & Wilson, J. F. (2016) · Nature Communications · doi:10.1038/ncomms11174 · Cited by 95
“Various SNPs in our associated interval have been associated with smoking quantity 20 , nicotine dependence 20 , lung cancer 21 , chronic obstructive pulmonary disease 22 , peripheral arterial disease 20 , alcohol dependence (independent of smoking status 23 ) and schizophrenia 24 .”
Berndt, A., Leme, A. S., & Shapiro, S. D. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201100627 · Cited by 101
“The latter is supported in light of the observations of significant associations between the CHRNA 3/5 locus and smoking behaviour in lung cancer (Spitz et al, 2008; Thorgeirsson et al, 2008).”
The development of personality across the lifespan
Donnellan, M. B., & Robins, R. W. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511596544.015 · Cited by 94
Genetic Basis for Susceptibility to Lung Cancer
Yokota, J., Shiraishi, K., & Kohno, T. (2010) · Advances in cancer research · doi:10.1016/b978-0-12-380890-5.00002-8 · Cited by 104
Light and intermittent cigarette smokers: a review (1989–2009)
Coggins, C. R. E., Murrelle, E. L., Carchman, R. A., & Heidbreder, C. A. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1675-4 · Cited by 94
Current Genetics and Epigenetics of Smoking/Tobacco-Related Cardiovascular Disease
Breitling, L. P. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.300157 · Cited by 90
“Intriguingly, one of the first studies investigating genetic determinants of smoking behavior on a genome-wide scale a priori included both a malignant and a cardiovascular phenotype as examples of smoking-related disease: single nucleotide polymorphisms in linkage disequilibrium with rs1051730 located on chromosome 1…”
BackgroundPhysical activity and genetic predisposition to obesity in a multiethnic longitudinal study
Reddon, H., Gerstein, H. C., Engert, J. C., Mohan, V., Bosch, J., Desai, D., Bailey, S. D., Díaz, R., Yusuf, S., Anand, S. S., et al. (2016) · Scientific Reports · doi:10.1038/srep18672 · Cited by 95
Multi-environment fitness landscapes of a tRNA gene
Li, C., & Zhang, J. (2018) · Nature Ecology & Evolution · doi:10.1038/s41559-018-0549-8 · Cited by 86
“In summary, we detected widespread G×E in the FLs of the yeast tRNA CCUArg gene across four environments, echoing accumulating reports of G×E in humans and model organisms 14,15,29,33 and supporting the importance of mapping FLs in multiple environments.”
Sears, C. R., & Mazzone, P. J. (2020) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2019.10.004 · Cited by 95
The Role of the Akt/mTOR Pathway in Tobacco Carcinogen–Induced Lung Tumorigenesis
Memmott, R. M., & Dennis, P. A. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0234 · Cited by 94
DNA variations in human and medical genetics: 25 years of my experience
Nakamura, Y. (2009) · Journal of Human Genetics · doi:10.1038/jhg.2008.6 · Cited by 110
A CHRNA5 smoking risk variant decreases the aversive effects of nicotine in humans
Jensen, K. P., DeVito, E. E., Herman, A. I., Valentine, G. W., Gelernter, J., & Sofuoglu, M. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.131 · Cited by 85
“…et al, 2010; Hung et al, 2008; Li et al, 2010; Liu et al, 2010; Saccone et al, 2010; Saccone et al, 2007; Sarginson et al, 2011; Spitz et al, 2008; Thorgeirsson et al, 2008; Tobacco and Genetics Consortium, 2010; Wang et al, 2009). rs16969968 encodes an amino-acid substitution in CHRNA5 that…”
BackgroundHancock, D. B., Reginsson, G. W., Gaddis, N. C., Chen, X., Saccone, N. L., Lutz, S. M., Qaiser, B., Sherva, R., Steinberg, S., Zink, F., et al. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.149 · Cited by 85
Self-citationThe CHRNA5–A3–B4 Gene Cluster and Smoking: From Discovery to Therapeutics
Lassi, G., Taylor, A. E., Timpson, N. J., Kenny, P. J., Mather, R. J., Eisen, T., & Munafò, M. R. (2016) · Trends in Neurosciences · doi:10.1016/j.tins.2016.10.005 · Cited by 85
“Further studies have highlighted that the same gene cluster is also associated with vulnerability to many smoking-associated diseases such as [346_TD$DIFF]COPD[347_TD$DIFF] and lung cancer [1,2,6,48,49].”
Chen, L., Hung, R. J., Baker, T. B., Horton, A. C., Culverhouse, R., Saccone, N. L., Cheng, I. C., Deng, B., Han, Y., Hansen, H. M., et al. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv100 · Cited by 92
“We found that genetic variation in CHRNA5, which strongly predicts risk for nicotine dependence (3–6), lung cancer (9,11), and COPD (10), also predicts delayed smoking cessation.”
BackgroundSelf-citationYoon, K., Park, J. H., Han, J., Park, S., Lee, G. K., Han, J., Zo, J. I., Kim, J., Lee, J. E., Takahashi, A., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq421 · Cited by 87
Ioannidis, J. P. A. (2009) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.108.833392 · Cited by 85
Genetic Relationship between Schizophrenia and Nicotine Dependence
Chen, J., Bacanu, S.-A., Yu, H., Zhao, Z., Jia, P., Kendler, K. S., Kranzler, H. R., Gelernter, J., Farrer, L., Minica, C., et al. (2016) · Scientific Reports · doi:10.1038/srep25671 · Cited by 82
“Some of these pathways (Calcium Signaling, Long-Term Potentiation, Cell Adhesion Molecules, and Regulation of Actin Cytoskeleton) had been reported to be involved in schizophrenia 27–32 , others (Cell Adhesion Molecules and Neuroactive Ligand-Receptor Interaction) had been implicated in ND 33,34 .”
BackgroundEnvironmental, genetic and epigenetic contributions to cocaine addiction
Pierce, R. C., Fant, B., Swinford-Jackson, S. E., Heller, E. A., Berrettini, W. H., & Wimmer, M. E. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0008-x · Cited by 97
LLPi: Liverpool Lung Project Risk Prediction Model for Lung Cancer Incidence
Marcus, M. W., Chen, Y., Raji, O. Y., Duffy, S. W., & Field, J. K. (2015) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-14-0438 · Cited by 89
“Genome-wide association studies have identified inherited susceptibility patterns for lung cancer at different loci (42-44) and several methylation (45-47) and microRNA biomarkers (48-51) associated with lung cancer have been identified.”
BackgroundGelernter, J., Kranzler, H. R., Sherva, R., Almasy, L., Herman, A. I., Koesterer, R., Zhao, H., & Farrer, L. A. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.08.025 · Cited by 83
“Similar smoking quantity-based findings have emerged (34), including from large meta-analyses (11–13,35).”
BackgroundReisenzein, R., & Weber, H. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511596544.007 · Cited by 84
Nicotinic acetylcholine receptor-mediated mechanisms in lung cancer
Improgo, M. R., Tapper, A. R., & Gardner, P. D. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.05.020 · Cited by 94
Chanock, S. J., & Hunter, D. J. (2008) · Nature · doi:10.1038/452537a · Cited by 89
Wassel, C. L., Loomba, R., Ix, J. H., Allison, M. A., Denenberg, J. O., & Criqui, M. H. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.06.023 · Cited by 85
Nicotinic acetylcholine receptors mediate lung cancer growth
Improgo, M. R., Soll, L. G., Tapper, A. R., & Gardner, P. D. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00251 · Cited by 92
“Multiple genome-wide association studies (GWAS) have implicated the CHRNB4/A3/A5 locus in nicotine dependence and lung cancer (Amos et al., 2008; Hung et al., 2008; Thorgeirsson et al., 2008).”
BackgroundPositive and Negative Effects of Alcohol and Nicotine and Their Interactions: A Mechanistic Review
Hurley, L. L., Taylor, R. E., & Tizabi, Y. (2011) · Neurotoxicity Research · doi:10.1007/s12640-011-9275-6 · Cited by 89
“Finally, we will comment on how these research findings potentially impact suggestions for cessation treat- ment for addicts and general heath management, and sug- gest lines of study that need to be pursued.”
BackgroundWinslow, U. C., Rode, L., & Nordestgaard, B. G. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyu276 · Cited by 85
Ji, X., Bossé, Y., Landi, M. T., Gui, J., Xiao, X., Qian, D. C., Joubert, P., Lamontagne, M., Li, Y., Gorlov, I. P., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05074-y · Cited by 89
Self-citationCHRNA3 rs1051730 Genotype and Short-Term Smoking Cessation
Munafo, M. R., Johnstone, E. C., Walther, D., Uhl, G. R., Murphy, M. F. G., & Aveyard, P. (2011) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntr106 · Cited by 83
Transcription Deregulation at the 15q25 Locus in Association with Lung Adenocarcinoma Risk
Falvella, F. S., Galvan, A., Frullanti, E., Spinola, M., Calabrò, E., Carbone, A., Incarbone, M., Santambrogio, L., Pastorino, U., & Dragani, T. A. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2107 · Cited by 80
Metadata
- Authors
- Thorgeirsson, T. E., Geller, F., Sulem, P., Rafnar, T., Wiste, A., Magnusson, K. P., Manolescu, A., Thorleifsson, G., Stefansson, H., Ingason, A., Stacey, S. N., Bergthorsson, J. T., Thorlacius, S., Gudmundsson, J., Jonsson, T., Jakobsdottir, M., Saemundsdottir, J., Olafsdottir, O., Gudmundsson, L. J., Bjornsdottir, G., Kristjansson, K., Skuladottir, H., Isaksson, H. J., Gudbjartsson, T., Jones, G. T., Mueller, T., Gottsäter, A., Flex, A., Aben, K. K. H., de Vegt, F., Mulders, P. F. A., Isla, D., Vidal, M. J., Asin, L., Saez, B., Murillo, L., Blondal, T., Kolbeinsson, H., Stefansson, J. G., Hansdottir, I., Runarsdottir, V., Pola, R., Lindblad, B., van Rij, A. M., Dieplinger, B., Haltmayer, M., Mayordomo, J. I., Kiemeney, L. A., Matthiasson, S. E., Oskarsson, H., Tyrfingsson, T., Gudbjartsson, D. F., Gulcher, J. R., Jonsson, S., Thorsteinsdottir, U., Kong, A., & Stefansson, K.
- Affiliations
- deCODE Genetics (Iceland) (IS)
- University of Otago (NZ)
- Convent Hospital of the Brothers of Saint John of God (AT)
- Skåne University Hospital (SE)
- Università Cattolica del Sacro Cuore (IT)
- Radboud University Medical Center (NL)
- Hospital Universitario Reina Sofía (ES)
- National University Hospital of Iceland (IS)
- Instituto de Nanociencia y Materiales de Aragón (ES)
- Corresponding author
- Thorgeirsson, Thorgeir E.
- ORCID
- Venue
- Nature
- Published
- 2008-04
- Volume
- 452
- Issue
- 7187
- Pages
- 638-642
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4539558
- OpenAlex
- W2118082971
- Cited by
- 1,523
- References
- 45
- Citations by year
- 2026: 21 · 2025: 24 · 2024: 29 · 2023: 41 · 2022: 33 · 2021: 36 · 2020: 94 · 2019: 48 · 2018: 56 · 2017: 79 · 2016: 80 · 2015: 107 · 2014: 91 · 2013: 100 · 2012: 145
- FWCI
- 120.54
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Hirsla (Landspítali University Hospital) (submittedVersion)
- Funders
- European Commission
- National Institute on Drug Abuse (R01DA017932)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Keywords
- nicotinic acetylcholine receptors, nicotine dependence, smoking quantity, lung cancer susceptibility, peripheral arterial disease, gene-environment interaction, genetic susceptibility, smoking-related diseases
- MeSH terms
- Chromosomes, Human, Pair 15, Europe, Female, Multigene Family, Genotype, Humans, Lung Neoplasms, Male, New Zealand, Receptors, Nicotinic, Smoking, Tobacco Use Disorder, Odds Ratio, Peripheral Vascular Diseases, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.